Kidney disease often progresses silently, causing irreversible damage before symptoms appear. Simple tests like blood ...
PLEASANTON, Calif., Oct. 29, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of expanded claims for the cobas® EGFR Mutation ...
When her relative couldn’t get on the waiting list for a kidney transplant, Dr. Nwamaka Eneanya had to step in. Tests showed his kidney function was not severe enough. But Eneanya, a physician who ...
MISSION HILLS, LOS ANGELES (KABC) -- A medical test for kidney function that adjusts its results for race is coming under increased scrutiny. Experts are saying the results for African-American ...
HILDEN, Germany, and TOKYO--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the ...
Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR, and KRAS mutations in NSCLC. This is an ASCO Meeting Abstract from the 2013 ASCO ...
DEAR DR. ROACH: I am a 73-year-old female. A recent blood test returned an eGFR (estimated glomerular filtration rate) of 59. My physician’s nurse told me that the test was normal. When I asked her ...
CHICAGO -- There is new hope for thousands of African Americans waiting for a new kidney. A test to determine placement on a transplant waiting list has been deemed flawed. The finding will have a ...
- Lung cancer causes more than 1.7 million deaths worldwide each year, with NSCLC accounting for about 85 percent of all cases[1] - The cobas EGFR Mutation Test v2 is FDA approved as a companion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback